Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs
- 31 October 2000
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 42 (4) , 281-285
- https://doi.org/10.1006/phrs.2000.0689
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)Epilepsy Research, 1999
- Hippocampal slices from long-term streptozotocin-injected rats are prone to epileptiform responsesNeuroscience Letters, 1998
- Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsyPublished by Elsevier ,1998
- Inhibition by levetiracetam of a non‐GABAA receptor‐associated epileptiform effect of bicuculline in rat hippocampusBritish Journal of Pharmacology, 1997
- Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmissionNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997
- ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivoEuropean Journal of Pharmacology, 1995
- Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsyEpilepsy Research, 1995
- Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and ratsEuropean Journal of Pharmacology, 1993
- Prolonged field bursts in the dentate gyrus: dependence on low calcium, high potassium, and nonsynaptic mechanismsJournal of Neurophysiology, 1992
- Epileptiform burst activity induced by potassium in the hippocampus and its regulation by GABA-mediated inhibitionJournal of Neurophysiology, 1987